We investigate the performance of a scheduling algorithm where the mobile terminals (MTs) may be turned off if they cause a level of interference greater than a given threshold. This approach, which is referred to as interference aware muting (IAM), may be regarded as an interference-aware scheme that is aimed to reduce the level of interference. We analyze its performance with the aid of stochastic geometry and compare it against other interference-unaware and interference-aware schemes, where the level of interference is kept under control in the power control scheme itself rather than in the scheduling process. IAM is studied in terms of average transmit power, mean and variance of the interference, coverage probability, spectral efficiency (SE), and binary rate (BR), which accounts for the amount of resources allocated to the typical MT. Simplified expressions of SE and BR for adaptive modulation and coding schemes are proposed, which better characterize practical communication systems. Our system-level analysis unveils that IAM increases the BR and reduces the mean and variance of the interference. It is proved that an operating regime exists, where the performance of IAM is independent of the cell association criterion, which simplifies the joint design of uplink and downlink transmissions.
The effect of oxyphenbuhzorne (Tandearil) on the seromucoid proteila and seromucoid-bound carbohydrates of Walker 256 carci~lon~a bearing rats has beer1 investigated. InitiaHy, treatment is associated with increased tumor growth and slappression of the anticipated glycoprotein response in the serum. After the eighth day, tumor growth ceases in treated animals and the serum glycoproteins manifest progressive elevations which are, however, less than those observed in untreated tumor-bearing controls. The survival time of treated animals exceeded that of untreated tramor-bearing animals, and treated animals were free of gross malignant disease a t the time of death.Studies from anany laboratories have amply confirmed the elevation. of plasma or serum glycoproteins that accompanies malignant disease in the human (1-5) and in the laboratory animal bearing a transplantable tumor (6-10). Available evidence would suggest that the observed elevation occurs largely, if not exclusively, in the seromucoid fraction of the plasma proteins (8,9). This fraction, which is not precipitable by boiling a t slightly acid pH, is defined as a group of protein-carbohydrate complexes occurring in plasma that are soluble in 0.6 M prchloric acid but insoluble in 1 1ll phosphotungstic acid (11).Recent investigations have focused on a search for the source of the elevated plasma glycoproteins observed in malignant disease and a wide variety of acute and chronic inflammatory states. I t appears clear that in the normal anirnlal the protein binding of carbohydrates and synthesis of glycoproteins occur in the
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.